Hebei Changshan Biochem Pharma (300255) — Cash Flow-to-Debt Ratio
Hebei Changshan Biochem Pharma (300255) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of CN¥-30.86 Million could theoretically repay 0% of its total liabilities (CN¥3.18 Billion) in one year. Explore how much of Hebei Changshan Biochem Pharma's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hebei Changshan Biochem Pharma Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Hebei Changshan Biochem Pharma across 17 annual periods. Also explore 300255 asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Hebei Changshan Biochem Pharma (2008–2024)
Year-by-year debt coverage analysis for Hebei Changshan Biochem Pharma. For market capitalisation and broader financial context, see Hebei Changshan Biochem Pharma (300255) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | CN¥56.22 Million | CN¥2.99 Billion | ▲ +56.1% |
| 2023 | 0.01x | CN¥33.73 Million | CN¥2.80 Billion | ▲ +1050.4% |
| 2022 | 0.00x | CN¥3.13 Million | CN¥2.98 Billion | ▼ -22.7% |
| 2021 | 0.00x | CN¥2.87 Million | CN¥2.12 Billion | ▲ +101.3% |
| 2020 | -0.11x | CN¥-183.58 Million | CN¥1.72 Billion | ▼ -124.2% |
| 2019 | -0.05x | CN¥-58.13 Million | CN¥1.22 Billion | ▼ -121.5% |
| 2018 | 0.22x | CN¥292.81 Million | CN¥1.32 Billion | ▲ +49.4% |
| 2017 | 0.15x | CN¥162.28 Million | CN¥1.09 Billion | ▼ -27.4% |
| 2016 | 0.20x | CN¥171.96 Million | CN¥842.59 Million | ▲ +505.1% |
| 2015 | -0.05x | CN¥-38.14 Million | CN¥757.07 Million | ▲ +63.4% |
| 2014 | -0.14x | CN¥-84.97 Million | CN¥617.87 Million | ▼ -224.5% |
| 2013 | -0.04x | CN¥-15.24 Million | CN¥359.78 Million | ▲ +82.4% |
| 2012 | -0.24x | CN¥-70.62 Million | CN¥292.77 Million | ▼ -381.4% |
| 2011 | 0.09x | CN¥17.04 Million | CN¥198.78 Million | ▼ -38.1% |
| 2010 | 0.14x | CN¥29.25 Million | CN¥211.25 Million | ▼ -38.7% |
| 2009 | 0.23x | CN¥24.21 Million | CN¥107.15 Million | ▲ +175.6% |
| 2008 | -0.30x | CN¥-30.83 Million | CN¥103.16 Million | — |